BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32514631)

  • 1. Management of the Small Renal Mass: a 2020 Update.
    Wilcox Vanden Berg RN; Basourakos SP; LaRussa S; McClure TD
    Curr Oncol Rep; 2020 Jun; 22(7):69. PubMed ID: 32514631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
    Patel N; Cranston D; Akhtar MZ; George C; Jones A; Leiblich A; Protheroe A; Sullivan M
    BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I.
    Campbell SC; Clark PE; Chang SS; Karam JA; Souter L; Uzzo RG
    J Urol; 2021 Aug; 206(2):199-208. PubMed ID: 34115547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study.
    Alam R; Patel HD; Osumah T; Srivastava A; Gorin MA; Johnson MH; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME; Pierorazio PM
    BJU Int; 2019 Jan; 123(1):42-50. PubMed ID: 30019484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving practice patterns for the management of small renal masses in the USA.
    Yang G; Villalta JD; Meng MV; Whitson JM
    BJU Int; 2012 Oct; 110(8):1156-61. PubMed ID: 22372984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.
    Heuer R; Gill IS; Guazzoni G; Kirkali Z; Marberger M; Richie JP; de la Rosette JJ
    Eur Urol; 2010 Feb; 57(2):223-32. PubMed ID: 19853989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness of Surgical Treatments for Small Renal Masses.
    Agrawal S; Sedlacek H; Kim SP
    Urol Clin North Am; 2017 May; 44(2):257-267. PubMed ID: 28411917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Small Renal Masses.
    Chenam A; Lau C
    Cancer Treat Res; 2018; 175():105-126. PubMed ID: 30168119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous core biopsy of small renal mass lesions: a diagnostic tool to better stratify patients for surgical intervention.
    Menogue SR; O'Brien BA; Brown AL; Cohen RJ
    BJU Int; 2013 Apr; 111(4 Pt B):E146-51. PubMed ID: 22805186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary management of small renal masses.
    Volpe A; Cadeddu JA; Cestari A; Gill IS; Jewett MA; Joniau S; Kirkali Z; Marberger M; Patard JJ; Staehler M; Uzzo RG
    Eur Urol; 2011 Sep; 60(3):501-15. PubMed ID: 21664040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of small renal masses: what is likely to change?
    Selli C; Turri FM; Mariani C; Manassero F
    Urologia; 2015; 82(4):193-202. PubMed ID: 26219473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Management of Small Renal Masses, Including Patient Selection, Renal Tumor Biopsy, Active Surveillance, and Thermal Ablation.
    Sanchez A; Feldman AS; Hakimi AA
    J Clin Oncol; 2018 Dec; 36(36):3591-3600. PubMed ID: 30372390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary Issues Surrounding Small Renal Masses: Evaluation, Diagnostic Biopsy, Nephron Sparing, and Novel Treatment Modalities.
    Leone AR; Diorio GJ; Spiess PE; Gilbert SM
    Oncology (Williston Park); 2016 Jun; 30(6):507-14. PubMed ID: 27323710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
    Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
    Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous Ablation Versus Nephrectomy for Small Renal Masses: Clinical Outcomes in a Single-Center Cohort.
    Lourenco P; Bilbey N; Gong B; Bahrabadi A; Halkier B
    Cardiovasc Intervent Radiol; 2018 Dec; 41(12):1892-1900. PubMed ID: 30088062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical removal of renal tumors with low metastatic potential based on clinical radiographic size: A systematic review of the literature.
    Patel HD; Semerjian A; Gupta M; Pavlovich CP; Johnson MH; Gorin MA; Allaf ME; Pierorazio PM
    Urol Oncol; 2019 Aug; 37(8):519-524. PubMed ID: 31202730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal ablation therapy for renal cancer in the era of active surveillance and minimally invasive partial nephrectomy.
    Ginzburg S; Tomaszewski JJ; Kutikov A
    Nat Rev Urol; 2017 Nov; 14(11):669-682. PubMed ID: 28895562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal Mass and Localized Renal Cancer: AUA Guideline.
    Campbell S; Uzzo RG; Allaf ME; Bass EB; Cadeddu JA; Chang A; Clark PE; Davis BJ; Derweesh IH; Giambarresi L; Gervais DA; Hu SL; Lane BR; Leibovich BC; Pierorazio PM
    J Urol; 2017 Sep; 198(3):520-529. PubMed ID: 28479239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.